In Vivo Evaluation Using Gamma Scintigraphy - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

In Vivo Evaluation Using Gamma Scintigraphy
The authors discuss gamma scintigraphy as a technique for in vivo evaluation of drugs and delivery systems.


Pharmaceutical Technology


Radiolabeling techniques

Several approaches for radiolabeling are available. Whole-dose radiolabeling, point radiolabeling, surrogate markers, and neutron activation are predominantly used (6, 9–12).

Whole-dose radiolabeling . Whole-dose radiolabeling uniformly incorporates radiolabeled-carrier particles within the formulation matrix during manufacture. This approach is particularly important when the key objective is to assess the release pattern of a drug from the dosage form over time.

Point radiolabeling . Point radiolabeling also is known as drill and fill, by which the radiolabeled-carrier particles are inserted into a hole drilled within the surface of a tablet, which is subsequently sealed. The radiolabel acts as a marker for location in the GI tract and also provides some information about the physical integrity of the dosage forms.

Surrogate markers . Surrogate markers generally are useful for several multiparticulate systems. In these studies, a second population (e.g., ion-exchange resin or nonpareil beads), labeled with a suitable radionuclide, is mixed with drug pellets. These radiolabeled pellets reveal the information on the location of the drug containing pellets in the GI tract, and data can be further correlated with a pharmacokinetic profile.

Neutron activation . Under neutron activation, a stable isotope is incorporated into the dosage form before its manufacture, which is followed by neutron irradiation of the intact dosage form. Thermal neutron irradiation converts the carefully selected stable isotopes (i.e., 152Sm or 170Er) into radioactive gamma-emitting isotopes (i.e., 153Sm or 171Er) that can be detected by external imaging devices.

Scintillation camera

Gamma camera, also called scintillation camera or Anger camera, is a device used to detect and image gamma radiation emitted from a radionuclide. A gamma camera is provided with a scintillator that exhibits the property of luminescence and transforms the gamma radiation into an emission of light. Monocrystals of sodium iodide, activated by thallium, is the most commonly used scintillator. A collimator made of lead is placed immediately in front of the crystal to stop and filter a stream of radiation arriving at an angle. A photomultiplier array and electronic circuitry are used for amplifying the light signal produced in the crystal, quantifying the intensity of the incident gamma rays, and locating its origin. It is thus possible to determine the distribution of the tracer on an image formed as a matrix of pixels (8). This image is subsequently computer-processed to accurately determine the distribution and relative concentration of a radioactive tracer element in the organs and tissues imaged, or in the so-called regions of interest.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
22%
To all process for new products only
12%
To select process for new products only
22%
To select processes for both new and legacy products
22%
Do not use QbD
24%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here